How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Are the population and subgroups appropriate and described correctly?
  • Question on Consultation

    Are the interventions described correctly?
  • Question on Consultation

    Are there any other technologies that should be included in the assessment?
  • Question on Consultation

    Have the care pathway and comparator been appropriately described?
  • Question on Consultation

    Is the place of the technologies in the pathway described appropriately?
  • Question on Consultation

    Are livers typically split at paediatric liver transplant centres?
  • Question on Consultation

    Are all of the outcomes suitable for inclusion in the assessment?
  • Question on Consultation

    Are there any additional outcomes which should be included, particularly for children and young people?
  • Question on Consultation

    Which outcomes are most relevant to children and young people?
  • Question on Consultation

    Are there any other patient issues that should be considered?
  • Question on Consultation

    Are there any other issues for the implementation and adoption of ex-situ machine technologies for liver transplants?
  • Question on Consultation

    Are there any changes that need to be made to the scope to eliminate unlawful discrimination and promote equality?
  • Question on Consultation

    Are there any additional potential equality or discrimination issues associated with this topic that need to be considered?
The content on this page is not current guidance and is only for the purposes of the consultation process.

8 Potential equality issues

NICE is committed to promoting equality of opportunity, eliminating unlawful discrimination and fostering good relations between people with protected characteristics and others.

  • End-stage liver disease can significantly affect people's daily living. Under the Equality Act 2010, a person has a disability if they have a physical or mental impairment that has a substantial and long-term effect on their ability to do typical day-to-day activities. Disease severity is an important factor in determining the allocation of liver transplants. People with more severe liver disease and higher risk of mortality, are generally prioritised for liver transplantation ahead of people with less severe liver disease and lower risk of mortality, although other factors may also be considered.

  • Adults from white or Asian backgrounds tend to wait less time for a liver transplant than adults from black or other ethnic minority backgrounds (NHS Blood and Transplant, 2024a).

  • All of the major religions and belief systems in the UK are open to the principles of organ donation and transplantation. Organ donation is a personal choice and views on the matter can vary even among individuals within the same faith (NHS Blood and Transplant).

  • There are different types of liver diseases that can be associated with alcohol, obesity, viral infection, and genetic factors. Overall, men are more likely to die from liver disease than women (British Liver Trust, 2024). In 2023/24, males represented 57% of deceased liver donors, 63% of transplant recipients and 55% of the active waiting list (NHS Blood and Transplant, 2024a).

Sex, disability, race and religion or belief are protected characteristics under the Equality Act (2010).

Additional considerations include:

  • In England, the risk of dying prematurely from alcoholic liver disease is higher in people from more deprived areas (Office for Health Improvement and Disparities, 2024). People experiencing homelessness who develop end-stage liver disease may not access healthcare services and may not receive the support they need.

  • Experts noted that some people living in rural locations may have experienced reduced levels of access to donor organs prior to the introduction of machine perfusion technologies, due to logistical considerations.